APA način citiranja (7. izdanje)

Normann, L. S., Haugen, M. H., Hongisto, V., Aure, M. R., Leivonen, S., Kristensen, V. N., . . . Mælandsmo, G. M. (2023). High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer. Public Library of Science (PLoS).

Čikaški stil citiranja (17. izdanje)

Normann, Lisa Svartdal, et al. High-throughput Screen in Vitro Identifies Dasatinib as a Candidate for Combinatorial Treatment with HER2-targeting Drugs in Breast Cancer. Public Library of Science (PLoS), 2023.

MLA način citiranja (9. izdanje)

Normann, Lisa Svartdal, et al. High-throughput Screen in Vitro Identifies Dasatinib as a Candidate for Combinatorial Treatment with HER2-targeting Drugs in Breast Cancer. Public Library of Science (PLoS), 2023.